NASDAQ:EQRX - Nasdaq - US26886C1071 - Common Stock - Currency: USD
TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 354.36M | 355.88M | 196.38M | 250.08M | 4.63M | |||
Research and Development | 242.28M | 228.50M | 118.11M | 224.39M | 1.15M | |||
Selling, General, and Administrative Expenses | 112.08M | 127.38M | 78.27M | 25.69M | 3.48M | |||
Operating Income | -354.36M | -355.88M | -196.38M | -250.08M | -4.63M | |||
Interest Income/Expense | 52.39M | 25.15M | 436.00K | 97.00K | 0.00 | |||
Other Income/Expense | 69.57M | 161.64M | 95.93M | 0.00 | -3.88M | |||
Income Before Taxes | -262.78M | -169.09M | -100.01M | -249.98M | -8.51M | |||
Net Income | -262.78M | -169.09M | -100.01M | -249.98M | -8.51M | |||
EBITDA | -353.59M | -354.94M | -195.19M | -249.74M | N/A | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.55 | -0.36 | -0.21 | -0.51 | -0.02 | |||
Non GAAP EPS | -0.55 | -0.36 | N/A | N/A | N/A | |||
Statistics |
All data in USD